Senti Biosciences Inc. (NASDAQ:SNTI) shares, rose in value on Wednesday, 08/03/22, with the stock price down by -10.51% to the previous day’s close as strong demand from buyers drove the stock to $2.30.
Actively observing the price movement in the last trading, the stock closed the session at $2.57, falling within a range of $2.10 and $2.43. Referring to stock’s 52-week performance, its high was $10.54, and the low was $1.59. On the whole, SNTI has fluctuated by 18.56% over the past month.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that SNTI’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of SNTI currently trading nearly 14.46% and -43.97% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.76, while the 7-day volatility ratio is showing 26.18% which for the 30-day chart, stands at 14.47%. Furthermore, Senti Biosciences Inc. (SNTI)’s average true range (ATR) is 0.35.
Data on historical trading for Senti Biosciences Inc. (NASDAQ:SNTI) indicates that the trading volumes over the past 10 days have averaged 6.36 million and over the past 3 months, they’ve averaged 1.24 million. According to company’s latest data on outstanding shares, there are 29.47 million shares outstanding.
Nearly 4.10% of Senti Biosciences Inc.’s shares belong to company insiders and institutional investors own 60.60% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.14 million shares as on Jul 14, 2022, resulting in a short ratio of 0.26. According to the data, the short interest in Senti Biosciences Inc. (SNTI) stood at 0.31% of shares outstanding as of Jul 14, 2022; the number of short shares registered in Jun 14, 2022 reached 47430.0. The stock has fallen by -76.67% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SNTI stock heading into the next quarter.